For individuals living with thyroid eye disease (TED), treatment options continue to evolve, and there is exciting news. Lumvoa™ (veligrotug-vvze), developed by Viridian Therapeutics, has recently received FDA approval, offering a new treatment option for adults living with thyroid eye disease.
We are proud to offer Lumvoa at our infusion centers across New York, New Jersey, Pennsylvania, Connecticut, Florida, Ohio, Tennessee, Kentucky, and Vermont, helping patients access innovative therapies in a comfortable, patient-centered environment.
Whether you’ve recently been diagnosed with thyroid eye disease or are exploring new treatment options, our experienced clinical team is here to support you every step of the way.
What Is Thyroid Eye Disease?
Thyroid eye disease (TED), sometimes called Graves’ eye disease, is an autoimmune condition that causes inflammation behind the eyes. While it is commonly associated with Graves’ disease, TED can affect people with other thyroid conditions as well.
Common symptoms include:
- Bulging eyes
- Eye pain or pressure
- Redness and swelling
- Double vision
- Dry or watery eyes
- Difficulty closing the eyelids
- Vision changes
For many patients, these symptoms can interfere with daily life, making it difficult to work, drive, read, or simply feel comfortable.
What Is Lumvoa?
Lumvoa is a newly FDA-approved infusion therapy developed specifically to treat thyroid eye disease. It works by targeting the insulin-like growth factor-1 receptor (IGF-1R), helping reduce the inflammation responsible for many of TED’s symptoms.
By addressing the underlying disease process, not just the symptoms, Lumvoa may help improve:
- Eye bulging (proptosis)
- Double vision
- Eye discomfort
- Swelling
- Overall quality of life
If your physician believes you may be a candidate, Lumvoa may become an important part of your treatment plan.
The Thrivewell Infusion Experience
Receiving an infusion shouldn’t add stress to your healthcare journey. At Thrivewell, we’ve created infusion centers designed around comfort, convenience, and exceptional patient care.
Patients receiving Lumvoa can expect:
- Private and semi-private infusion suites
- Comfortable reclining chairs
- Complimentary snacks and beverages
- Experienced infusion nurses
- Flexible appointment scheduling
- A calm, welcoming environment
- Personalized care from start to finish
Our goal is to make every infusion experience as comfortable as possible while delivering the highest level of clinical care.
Our dedicated patient access team works directly with physicians, specialty pharmacies, and insurance providers to help coordinate benefits investigations, prior authorizations, appeals when necessary, and financial assistance programs when available.
With more than 35+ infusion centers, patients have convenient access to high-quality infusion therapy close to home.
If you or a loved one has been diagnosed with thyroid eye disease and would like to learn more about Lumvoa treatment, Thrivewell Infusion is here to help.
Our team can work with your referring physician to coordinate care and answer questions about the infusion process.
Frequently Asked Questions
What is Lumvoa?
Lumvoa is an FDA-approved infusion medication used to treat adults with thyroid eye disease.
What condition does Lumvoa treat?
Lumvoa is used to treat thyroid eye disease (TED), an autoimmune condition affecting the tissues around the eyes.
Where can I receive Lumvoa infusions?
Thrivewell Infusion offers Lumvoa at locations throughout New York, New Jersey, Pennsylvania, Connecticut, Florida, Ohio, Tennessee, Kentucky, and Vermont.
Does Thrivewell help with insurance?
Yes. Our patient access specialists assist with insurance verification, prior authorizations, and financial assistance programs when available.
How do I get started?
Speak with your healthcare provider about whether Lumvoa may be appropriate for you. If prescribed, the Thrivewell team can help coordinate your infusion appointments.